Govinda Ramakrishna
Govinda Ramakrishna was born in Kerala in India and has lived in India, United States and Canada. He has travelled extensively in Europe, United States, Canada, Australia, Russia ( including Siberia ), Middle East and Japan. At present lives with his wife, Rema Kumar, in Toronto, Canada during summer months and in Kochi, India during winter.
Govinda is a Mechanical Engineer by profession and retired as the President and CEO of a large Engineering Company in India. After retirement he was on the Board of Directors of a number of Engineering companies and is an Engineering and Management consultant.
Govinda was diagnosed with low grade, Gleason 6, Prostate Cancer in 2015 and chose to opt for Active Surveillance protocol. After almost two years in Active Surveillance, his PSA level went up to 5.4 and was advised to do a second biopsy. The results showed an Intermediate stage, medium risk Prostate Cancer with a Gleason score of 7 ( 4+3 ). He was strongly advised by his Urologist to start on active treatment regimen at the earliest.
Being a detailed oriented person by nature and training, Govinda decided to be the CEO of his own health and treatment planning with invaluable support from his wife Rema, son Vinu Warrier, daughter Dr.Malini Warrier and their spouses.
After lot of research and consultations with 5 different Urologists and Radiation Oncologists, Govinda decided to sign up for an International Clinical Trial, called PACE, and was treated with SBRT ( Cyber knife ), a focused, high dose version of External Beam Radiation. The treatment and recovery phase went off well and after about 6 years there are no serious side effects and he leads a normal busy life. The Clinical trial was a success and SBRT was approved by the Canadian Health System at the end of the trial.
Govinda is an active member of a number of Prostate Cancer Support Groups in United States and Canada and is an Accredited Peer Navigator for Prostate Cancer Patients in Sunnybrook Odette Cancer Centre in Toronto, Canada, which is a “Centre of Excellence “for Cancer treatment in Canada. He is a regular Volunteer at the Urology Clinic in Odette Cancer Centre.
Govinda feels that ASPI can be the pioneer in India for promoting Active Surveillance as the preferred first choice for management of Low and Low Intermediate risk Prostate Cancer. As of now, Active Surveillance is not considered as a serious long term option in India.